Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties
US7598273B2 · kind B2 · utility
18Cited by
41References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2006 |
| Grant date | Oct 6, 2009 |
| Priority date | — |
| Expiry date | Sep 15, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Chemical syntheses and medical uses of novel inhibitors of the gastric H+, K+-ATPase for the treatment and/or management of duodenal ulcers, heartburn, acid reflux, other conditions mediated by gastric acid secretion and/or psoriasis are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.